首页 | 本学科首页   官方微博 | 高级检索  
     


Cyclophosphamide’s addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide‐dexamethasone treatment
Authors:Laura Cesini  Agostina Siniscalchi  Sara Grammatico  Alessandro Andriani  Alessia Fiorini  Luca De Rosa  Tommaso Za  Angela Rago  Tommaso Caravita  Maria Teresa Petrucci
Affiliation:1. Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy;2. Institute of Haematology, S. Eugenio Hospital, Rome, Italy;3. Department of Haematology, Nuovo Regina Margherita Hospital, Rome, Italy;4. Department of Haematology, Belcolle Hospital, Viterbo, Italy;5. Department of Haematology, S. Camillo Hospital, Rome, Italy;6. Institute of Haematology, Catholic University, Rome, Italy;7. Department of Cellular Biotechnologies and Haematology, Polo Pontino, Sapienza University of Rome, Latina, Italy
Abstract:
Keywords:biochemical relapse  cyclophosphamide  dexamethasone, lenalidomide  relapsed/refractory multiple myeloma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号